Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate Ringer vs saline hydration to prevent contrast-associated acute kidney injury in CKD
ChiCTR2400079751Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jan 2024
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate ringer's solution in Postcontrast Acute Kidney Injury (PC-AKI), chronic kidney disease (CKD) and coronary arteriosclerosis (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Serum creatinine, Serum cystatin C and 1 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
sodium bicarbonate ringer's solution
03
Conditions
Postcontrast Acute Kidney Injury (PC-AKI)chronic kidney disease (CKD)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2400079751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079751.